Search research articles
Contact Us
Filters
Showing results (21-30 of 124) with videos related to
Page
of 13
Sort By:
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
July 11, 2006
Intensified external-beam radiation therapy improves the outcome of stage 4 neuroblastoma in children > 1 year with residual local disease
Thorsten Simon, Barbara Hero, Rudolf Bongartz, et al.
Pediatric Blood & Cancer
|
February 8, 2011
Treatment and outcomes of patients with relapsed, high-risk neuroblastoma: results of German trials
Thorsten Simon, Frank Berthold, Arndt Borkhardt, et al.
Klinische Padiatrie
|
September 16, 2024
[Nursing and medical delegable measures for children and adolescents with cancer as outpatient outreach care - The pilot project KIK HomeCare]
Rebecca Toenne, Rebecca Kristiment, Katharina Waack, et al.
European Journal of Radiology
|
April 17, 2009
Focal nodular hyperplasia of the liver in longterm survivors of neuroblastoma: how much diagnostic imaging is necessary?
Gabriele Benz-Bohm, Barbara Hero, Axel Gossmann, et al.
Pediatric Blood & Cancer
|
September 23, 2016
Lack of immunocytological GD2 expression on neuroblastoma cells in bone marrow at diagnosis, during treatment, and at recurrence
Roswitha Schumacher-Kuckelkorn, Ruth Volland, Anke Gradehandt, et al.
Clinical Journal of Oncology Nursing
|
November 18, 2017
Computer-Based Exercise Program: Effects of a 12-Week Intervention on Mood and Fatigue in Pediatric Patients With Cancer
Anna-Maria Platschek, Laura Kehe, Vera Abeln, et al.
BMC Cancer
|
January 20, 2011
Long term outcome of high-risk neuroblastoma patients after immunotherapy with antibody ch14.18 or oral metronomic chemotherapy
Thorsten Simon, Barbara Hero, Andreas Faldum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 2004
Consolidation treatment with chimeric anti-GD2-antibody ch14.18 in children older than 1 year with metastatic neuroblastoma
Thorsten Simon, Barbara Hero, Andreas Faldum, et al.
Journal of Pediatric Surgery
|
October 13, 2017
Retrospective analysis of relapsed abdominal high-risk neuroblastoma
Martin Dübbers, Thorsten Simon, Frank Berthold, et al.
British Journal of Cancer
|
September 26, 2019
Correction: Long-term outcomes of the GPOH NB97 trial for children with high-risk neuroblastoma comparing high-dose chemotherapy with autologous stem cell transplantation and oral chemotherapy as consolidation
Frank Berthold, Angela Ernst, Barbara Hero, et al.
Page
of 13
Search research articles
Search
Showing results (21-30 of 124) with videos related to
Sort By:
Page
of 13
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
July 11, 2006
Intensified external-beam radiation therapy improves the outcome of stage 4 neuroblastoma in children > 1 year with residual local disease
Thorsten Simon, Barbara Hero, Rudolf Bongartz, et al.
Pediatric Blood & Cancer
|
February 8, 2011
Treatment and outcomes of patients with relapsed, high-risk neuroblastoma: results of German trials
Thorsten Simon, Frank Berthold, Arndt Borkhardt, et al.
Klinische Padiatrie
|
September 16, 2024
[Nursing and medical delegable measures for children and adolescents with cancer as outpatient outreach care - The pilot project KIK HomeCare]
Rebecca Toenne, Rebecca Kristiment, Katharina Waack, et al.
European Journal of Radiology
|
April 17, 2009
Focal nodular hyperplasia of the liver in longterm survivors of neuroblastoma: how much diagnostic imaging is necessary?
Gabriele Benz-Bohm, Barbara Hero, Axel Gossmann, et al.
Pediatric Blood & Cancer
|
September 23, 2016
Lack of immunocytological GD2 expression on neuroblastoma cells in bone marrow at diagnosis, during treatment, and at recurrence
Roswitha Schumacher-Kuckelkorn, Ruth Volland, Anke Gradehandt, et al.
Clinical Journal of Oncology Nursing
|
November 18, 2017
Computer-Based Exercise Program: Effects of a 12-Week Intervention on Mood and Fatigue in Pediatric Patients With Cancer
Anna-Maria Platschek, Laura Kehe, Vera Abeln, et al.
BMC Cancer
|
January 20, 2011
Long term outcome of high-risk neuroblastoma patients after immunotherapy with antibody ch14.18 or oral metronomic chemotherapy
Thorsten Simon, Barbara Hero, Andreas Faldum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 2004
Consolidation treatment with chimeric anti-GD2-antibody ch14.18 in children older than 1 year with metastatic neuroblastoma
Thorsten Simon, Barbara Hero, Andreas Faldum, et al.
Journal of Pediatric Surgery
|
October 13, 2017
Retrospective analysis of relapsed abdominal high-risk neuroblastoma
Martin Dübbers, Thorsten Simon, Frank Berthold, et al.
British Journal of Cancer
|
September 26, 2019
Correction: Long-term outcomes of the GPOH NB97 trial for children with high-risk neuroblastoma comparing high-dose chemotherapy with autologous stem cell transplantation and oral chemotherapy as consolidation
Frank Berthold, Angela Ernst, Barbara Hero, et al.
Page
of 13